Talktalk Telecom Group (LON:TALK) Stock Rating Kept at Deutsche; Select Medical (SEM) Has 1.45 Sentiment

August 10, 2018 - By Billy Entrekin

TalkTalk Telecom Group PLC (LON:TALK) Logo

Select Medical Corp (SEM) investors sentiment increased to 1.45 in Q1 2018. It’s up 0.35, from 1.1 in 2017Q4. The ratio improved, as 93 investment professionals opened new and increased holdings, while 64 decreased and sold their equity positions in Select Medical Corp. The investment professionals in our database reported: 100.83 million shares, up from 100.69 million shares in 2017Q4. Also, the number of investment professionals holding Select Medical Corp in top ten holdings was flat from 1 to 1 for the same number . Sold All: 14 Reduced: 50 Increased: 56 New Position: 37.

Talktalk Telecom Group (LON:TALK) stock Buy was kept at Deutsche in a research note issued on Friday, 10 August.

Among 12 analysts covering TalkTalk Telecom Group PLC (LON:TALK), 3 have Buy rating, 4 Sell and 5 Hold. Therefore 25% are positive. TalkTalk Telecom Group PLC has GBX 180 highest and GBX 85 lowest target. GBX 114.30’s average target is -2.06% below currents GBX 116.7 stock price. TalkTalk Telecom Group PLC had 23 analyst reports since February 13, 2018 according to SRatingsIntel. The rating was maintained by Barclays Capital with “Equal Weight” on Wednesday, July 11. The stock has “Sell” rating by Numis Securities on Wednesday, April 4. The rating was maintained by Deutsche Bank with “Buy” on Monday, July 9. The company was maintained on Tuesday, March 27 by Citigroup. Numis Securities maintained the shares of TALK in report on Wednesday, July 18 with “Reduce” rating. Barclays Capital maintained it with “Equal Weight” rating and GBX 130 target in Monday, June 4 report. The stock of TalkTalk Telecom Group PLC (LON:TALK) earned “Reduce” rating by Numis Securities on Tuesday, July 3. The firm has “Underperform” rating given on Thursday, July 12 by Credit Suisse. The rating was maintained by Goldman Sachs on Thursday, March 29 with “Sell”. Bank of America upgraded the shares of TALK in report on Wednesday, June 13 to “Buy” rating.

The stock decreased 1.27% or GBX 1.5 during the last trading session, reaching GBX 116.7. About 930,942 shares traded. TalkTalk Telecom Group PLC (LON:TALK) has 0.00% since August 10, 2017 and is . It has underperformed by 12.57% the S&P500.

TalkTalk Telecom Group PLC provides fixed line, TV, and mobile telecommunications services. The company has market cap of 1.33 billion GBP. It offers landline, broadband, fiber, TV, and mobile services, including fixed price plans and unlimited broadband usage, as well as HomeSafe, a network security and filtering system. It currently has negative earnings. The firm also provides various business-grade communications services and products, including Internet access, data, voice, and mobile.

Select Medical Holdings Corporation, through its subsidiary, Select Medical Corporation, operates specialty hospitals, outpatient rehabilitation clinics, and occupational medicine centers in the United States. The company has market cap of $2.55 billion. The companyÂ’s Specialty Hospitals segment operates long term acute care hospitals and inpatient acute rehabilitative hospitals. It has a 12.67 P/E ratio. This segment offers various medical services for the treatment of respiratory failure, neuromuscular disorders, traumatic brain and spinal cord injuries, strokes, non-healing wounds, cardiac disorders, renal disorders, and cancer.

The stock decreased 2.58% or $0.5 during the last trading session, reaching $18.85. About 323,509 shares traded. Select Medical Holdings Corporation (SEM) has risen 31.29% since August 10, 2017 and is uptrending. It has outperformed by 18.72% the S&P500. Some Historical SEM News: 02/04/2018 – Fidelity Select Medical Equipment Adds Edwards Life; 10/04/2018 – Select Medical at Deutsche Bank Health Care Conference May 8; 03/05/2018 – Select Medical 1Q EPS 25c; 30/04/2018 – Fidelity Select Medical Equipment Adds Teleflex, Exits CVS; 29/03/2018 Select Medical Closes Below 200-Day Moving Average: Technicals; 03/05/2018 – Select Medical 1Q Net $33.7M; 03/05/2018 – Select Medical 1Q Rev $1.25B; 16/05/2018 – Call for Papers Now Open For 6th Annual National Post-Acute Care Safety and Quality Summit; 03/05/2018 – SELECT MEDICAL HOLDINGS REAFFIRMS 2018 OUTLOOK; 03/05/2018 – Baylor Scott & White Health and Select Medical Expand Joint Venture into the Austin Area

Hood River Capital Management Llc holds 2.36% of its portfolio in Select Medical Holdings Corporation for 2.44 million shares. Broadview Advisors Llc owns 530,080 shares or 1.5% of their US portfolio. Moreover, Orbimed Advisors Llc has 1.09% invested in the company for 5.07 million shares. The Texas-based Smith Graham & Co. Investment Advisors Lp has invested 0.94% in the stock. Monarch Partners Asset Management Llc, a Massachusetts-based fund reported 566,900 shares.

More recent Select Medical Holdings Corporation (NYSE:SEM) news were published by: Globenewswire.com which released: “Report: Developing Opportunities within Select Medical, Extreme Networks, Matador Resources, Owens-Illinois …” on August 10, 2018. Also Seekingalpha.com published the news titled: “Tracking Ken Fisher’s Fisher Asset Management Portfolio – Q2 2018 Update” on July 18, 2018. Benzinga.com‘s news article titled: “Earnings Scheduled For August 2, 2018” with publication date: August 02, 2018 was also an interesting one.

Analysts await Select Medical Holdings Corporation (NYSE:SEM) to report earnings on November, 1. They expect $0.18 earnings per share, up 28.57% or $0.04 from last year’s $0.14 per share. SEM’s profit will be $24.37 million for 26.18 P/E if the $0.18 EPS becomes a reality. After $0.31 actual earnings per share reported by Select Medical Holdings Corporation for the previous quarter, Wall Street now forecasts -41.94% negative EPS growth.

Select Medical Holdings Corporation (NYSE:SEM) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: